Prostate Cancer UK welcomes today's government announcement of billions in additional funds for NHS England to spend on drugs and cancer diagnosis up to 2020-21.
The Treasury have just announced £2billion of extra funding for new drugs for the NHS in England, as well as an investment of £300million per year until 2020-21 for cancer diagnostics.
"This commitment to improved diagnosis of cancer and funding for drugs is good news for men with and at risk of prostate cancer in England," says Karen Stalbow, our Head of Policy, Knowledge and Impact.
"It’s vitally important that we change the way prostate cancer is diagnosed. We need to find a way to make sure that we only diagnose those prostate cancers that need to be treated, and neither biopsy nor treat clinically insignificant cancers.
"Without this, too many men will continue to have unnecessary treatments that often leave them with life-changing side-effects. It is vital that the new government investment enables progress in the diagnosis of prostate cancer in men."
New clinically beneficial treatments must be made available to the men that need them as quickly as possible and for as long as they need them.
Currently, many men with prostate cancer in England struggle to get access to the new drugs and treatments they need.
"New clinically beneficial treatments must be made available to the men that need them as quickly as possible and for as long as they need them," says Karen. "The money should be made available by government for drugs, including improved access to off-patent, repurposed drugs."